Authors
Paul England

Dr Paul England

Senior Professional Support Lawyer

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More
Authors
Paul England

Dr Paul England

Senior Professional Support Lawyer

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

18 April 2019

Answering one question and raising others – the CJEU on SPCs for new formulations

This month on Synapse

Answering one question and raising others - the CJEU on SPCs for new formulations

Anja Lunze explains the latest ruling of the CJEU on SPCs, concerning whether new formulations of an active ingredient can be protected.

Territorial Licensing

We explore the practice of geographical licensing, by which the owner of the rights to a product grants to a licensee the exclusive right to develop and/or commercialise the product in a specific country or territory only.

The UK Supreme Court rules on inventive step

Paul England explains the meaning of the ruling on inventive step in the UK Supreme Court decision Actavis v ICOS

Judicial review of marketing authorisation refused

Angus Milne reviews the decision by the UK Administrative Court to refuse a judicial review of the grant of a marketing authorisation for a generic medicinal product, DexEP.

Brexit update – 'Grandfathering' marketing authorisations

Paul England provides the latest update on the date of Brexit and guidance from the MHRA and PMCPA on 'grandfathering'.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Life sciences & healthcare

Synapse - January 2020

16 January 2020

by multiple authors

Click here to find out more
Life sciences & healthcare

Synapse - December 2019

19 December 2019

by multiple authors

Click here to find out more
Life sciences & healthcare

Synapse - November 2019

26 November 2019

by Verena Bertram and Dr Paul England

Click here to find out more